Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast Cancer

New Directions in the Treatment of Breast Cancer: Bringing Biology to the Clinic and BackПодробнее

The OncoAlert Colloquium Day 3 Breast CancerПодробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

The 2022 OncoAlert Colloquium DAY 1: Breast CancerПодробнее

Dr. Hope Rugo – ESMO 2022 – Exploring the latest trial data & advances in breast cancer treatmentsПодробнее

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment ApproachesПодробнее

The OncoAlert Colloquium Day 3 Breast CancerПодробнее

Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast CancerПодробнее

UCSF Bay Area Breast Cancer Forum: Updates from ESMO 2020 2020: New Developments in TreatmentПодробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

Dr. Tripathy on Standard and Emerging Treatment Advances for HER2+ Breast CancerПодробнее

“Key Breakthroughs in the Field of Breast Cancer Treatment” by Dr. Hope RugoПодробнее